An experimental compound called AP503 significantly strengthened bones in mice by activating GPR133, a receptor that boosts bone formation while slowing bone loss. Because the same treatment has also been linked to stronger muscles, researchers see intriguing potential for combating age-related decline and osteoporosis.
More in Research
Venus’s pale yellow clouds may hide something surprisingly dark
September 13, 2026
Scientists find water was fueling volcanoes 3 billion years ago
September 13, 2026
A hidden compound in healthy foods may worsen IBD
September 13, 2026
Ozempic and Wegovy may raise hair loss risk in some men
September 13, 2026
Scientists discover a hidden switch that shuts down inflammation
September 13, 2026
CERN finds gluons behaving strangely deep inside atomic nuclei
September 12, 2026
Latest News
‘Back in Black’ Director on Lovable Serial Killer Doing “Bad Things for the Right Reasons” in Christopher Walken-Starrer
September 13, 2026
Fina Strazza to Star in, Produce Romantic Drama ‘Any Way You Want Me’ (Exclusive)
September 13, 2026
Toronto: Irene Dionisio’s ‘IDDA’ Lands at FilmClub Distribuzione for Italy (Exclusive)
September 13, 2026
Brics business council pushes supply-chain resilience, AI cooperation
September 13, 2026
Ralph Lauren faces flak for ‘stealing’ Indian craft: What is zardozi embroidery featured on New York Fashion Week gown?
September 13, 2026
‘Words Are Weapons’: Michaël R. Roskam on Turning a WWII Fake-Newspaper Prank Into a Heist Movie
September 13, 2026